Research by Weber et al. [60] demonstrated that tumor-secreted IL-6 induces CCR5 expression in a STAT3-dependent manner, resulting in increased immunosuppressive activity of MDSCs and subsequent inhibition of CD8+ T cell function in a mouse melanoma model. This evidence concerns the gene CD8A and melanoma.